Published in J Nucl Med on February 01, 2001
Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation (2007) 3.85
Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev (2010) 2.70
A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res (2009) 2.30
64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression. Bioconjug Chem (2007) 1.79
Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression. Proc Natl Acad Sci U S A (2005) 1.72
An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution. Biomacromolecules (2005) 1.70
Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. Cancer Biother Radiopharm (2009) 1.70
Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). Acc Chem Res (2009) 1.49
A review of imaging techniques for systems biology. BMC Syst Biol (2008) 1.42
Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA. PLoS One (2011) 1.36
In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Bioconjug Chem (2010) 1.24
Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging. Q J Nucl Med Mol Imaging (2007) 1.17
(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity. Nucl Med Biol (2009) 1.14
A comparison of PET imaging characteristics of various copper radioisotopes. Eur J Nucl Med Mol Imaging (2005) 1.12
Fluorinated tracers for imaging cancer with positron emission tomography. Eur J Nucl Med Mol Imaging (2004) 1.11
Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors. J Nucl Med (2008) 1.10
Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling. Bioconjug Chem (2008) 1.03
Positron emission tomography imaging of cancer biology: current status and future prospects. Semin Oncol (2011) 1.02
Gene therapy imaging in patients for oncological applications. Eur J Nucl Med Mol Imaging (2005) 1.01
Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma. Nucl Med Biol (2007) 0.97
Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probe. PLoS One (2011) 0.97
A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours. Eur J Nucl Med Mol Imaging (2008) 0.97
First-in-human uPAR PET: Imaging of Cancer Aggressiveness. Theranostics (2015) 0.92
Copper(II) cyclam-based complexes for radiopharmaceutical applications: synthesis and structural analysis. Dalton Trans (2007) 0.92
Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy. Cancer Biol Ther (2011) 0.90
Update of PET and PET/CT for hepatobiliary and pancreatic malignancies. HPB (Oxford) (2005) 0.90
Workshop on the production, application and clinical translation of ''non-standard'' PET nuclides: a meeting report. Q J Nucl Med Mol Imaging (2007) 0.90
Targeted molecular imaging in oncology: focus on radiation therapy. Semin Radiat Oncol (2008) 0.89
A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT. EJNMMI Res (2011) 0.88
One-step and one-pot-two-step radiosynthesis of cyclo-RGD-(18)F-aryltrifluoroborate conjugates for functional imaging. Am J Nucl Med Mol Imaging (2013) 0.87
A novel side-bridged hybrid phosphonate/acetate pendant cyclam: synthesis, characterization, and 64Cu small animal PET imaging. Bioorg Med Chem (2008) 0.87
Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates. Eur J Nucl Med Mol Imaging (2007) 0.84
Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals. J Labelled Comp Radiopharm (2013) 0.84
Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors. Scand J Gastroenterol (2015) 0.83
PET and SPECT Imaging of Tumor Biology: New Approaches towards Oncology Drug Discovery and Development. Curr Comput Aided Drug Des (2008) 0.81
Applications of molecular imaging. Prog Mol Biol Transl Sci (2010) 0.81
Quantum mechanics/molecular mechanics investigation of the mechanism of phosphate transfer in human uridine-cytidine kinase 2. Org Biomol Chem (2009) 0.80
Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies? Cancer Biother Radiopharm (2008) 0.80
Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes. Dalton Trans (2008) 0.79
Translational imaging endpoints to predict treatment response to novel targeted anticancer agents. Drug Resist Updat (2011) 0.78
Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [(18)F]-tetrafluoroborate. EJNMMI Res (2015) 0.78
QSAR studies of copper azamacrocycles and thiosemicarbazones: MM3 parameter development and prediction of biological properties. J Med Chem (2005) 0.78
Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate. Mol Imaging (2014) 0.76
Copper-64 Radiopharmaceuticals for Oncologic Imaging. PET Clin (2009) 0.76
Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management. Curr Opin Endocrinol Diabetes Obes (2016) 0.76
Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection. PLoS One (2014) 0.76
Dual tracer functional characterization of metastatic gastric carcinoid. Indian J Nucl Med (2013) 0.75
Nuclear medicine imaging and therapy of neuroendocrine tumours. Cancer Imaging (2006) 0.75
Somatostatin analogues labeled with copper radioisotopes: current status. J Radioanal Nucl Chem (2017) 0.75
Sex work, drug use, HIV infection, and spread of sexually transmitted infections in Moscow, Russian Federation. Lancet (2005) 3.28
Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl Med Biol (1997) 3.25
Preparation and standardization of the sorbent used in the fluorescent treponemal antibody-absorption (FTA-ABS) test. Health Lab Sci (1967) 2.43
Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg (2001) 2.40
Selective culture screening for penicillinase-producing Neisseria gonorrhoeae. Lancet (1977) 2.28
Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis (1998) 2.27
Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. J Clin Oncol (2001) 2.20
A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2001) 2.15
Recurrence in the axilla after sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol (2002) 2.03
FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol (2000) 1.96
Jacob Freud and talmudic teachings. Am J Psychoanal (1994) 1.91
Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol (1996) 1.88
Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol (1997) 1.77
Evaluation of the phadebact gonococcus test, a coagglutination procedure for confirmation of Neisseria gonorrhoeae. J Clin Microbiol (1980) 1.76
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci U S A (2000) 1.69
Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol (2001) 1.64
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med (1999) 1.62
Decline in sexually transmitted disease prevalence in female Bolivian sex workers: impact of an HIV prevention project. AIDS (1998) 1.59
Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery (2001) 1.57
Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis (1998) 1.55
The in vivo behavior of copper-64-labeled azamacrocyclic complexes. Nucl Med Biol (1998) 1.52
Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother (2008) 1.51
Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. J Nucl Med (2001) 1.51
Extended-spectrum beta-lactamases: epidemiology, detection, and treatment. Pharmacotherapy (2001) 1.46
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol (1997) 1.40
Immunochemical parameters of some commercial conjugates for the fluorescent treponemal antibody-absorption test. Infect Immun (1972) 1.39
Ab externo sulcus fixation. Ophthalmic Surg (1991) 1.39
A review of alternative approaches in the management of iatrogenic femoral pseudoaneurysms. Ann R Coll Surg Engl (1999) 1.38
Nutritional status of Mexican American preschool children in a border town. Am J Clin Nutr (1974) 1.36
Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. Clin Cancer Res (1996) 1.35
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med (1995) 1.34
Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg (1998) 1.30
An improved antigen for the FTA-ABS test. Health Lab Sci (1970) 1.30
Copper-64-labeled antibodies for PET imaging. J Nucl Med (1992) 1.29
Urinary leukocyte esterase test: a screening method for the detection of asymptomatic chlamydial and gonococcal infections in men. J Infect Dis (1992) 1.29
Tuberculous peritonitis--report of 30 cases and review of the literature. Q J Med (1985) 1.28
An investigation of genital ulcers in Jackson, Mississippi, with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. J Infect Dis (1998) 1.26
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum (2000) 1.25
Brain metastases from non-central nervous system tumors: evaluation with PET. Radiology (1993) 1.24
Evaluation of the PACE 2 Neisseria gonorrhoeae assay by three public health laboratories. J Clin Microbiol (1993) 1.24
Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. J Nucl Med (1998) 1.22
RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J Nucl Med (1995) 1.21
Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. J Nucl Med (1991) 1.21
Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu. Proc Natl Acad Sci U S A (1996) 1.20
Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg (1997) 1.18
Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy. Proc Natl Acad Sci U S A (2001) 1.17
High purity production and potential applications of copper-60 and copper-61. Nucl Med Biol (1999) 1.15
Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2. J Nucl Med (1995) 1.13
Automated fluorescent treponemal antibody test: instrument and evaluation. Appl Microbiol (1970) 1.12
Radical surgery for malignant tumors of the ear. Arch Otolaryngol (1966) 1.12
Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model. Clin Cancer Res (1999) 1.12
Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. AJR Am J Roentgenol (1997) 1.11
The "tie-over dressing" refined. Plast Reconstr Surg (2001) 1.11
Temporal bone resection. Review of 100 cases. Arch Otolaryngol (1975) 1.08
Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells. Ann Nucl Med (2001) 1.06
Plasmacytoma of paranasal sinuses and nasal cavity. Arch Otolaryngol (1973) 1.06
Small animal imaging. current technology and perspectives for oncological imaging. Eur J Cancer (2002) 1.05
PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology (1992) 1.05
Preclinical evaluation of fluorine-18-labeled androgen receptor ligands in baboons. J Nucl Med (1996) 1.05
Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine. J Nucl Med (1998) 1.05
Cancer of the nasal cavity and paranasal sinuses. J Laryngol Otol (1972) 1.02
Surgical management of tumors of the middle ear and mastoid. J Laryngol Otol (1983) 1.01
Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors. Neoplasia (2000) 1.01
Vertical distribution of water in the atmosphere of venus: a simple thermochemical explanation. Science (1990) 1.00
Multimodality image registration quality assurance for conformal three-dimensional treatment planning. Int J Radiat Oncol Biol Phys (2001) 0.99
Maternal health in the English aristocracy: myths and realities (1790-1840). J Soc Hist (1983) 0.98
Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia. Clin Ther (2000) 0.98
Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. Nucl Med Biol (1999) 0.98
High rate of bacterial vaginosis among women with intrauterine devices in Manado, Indonesia. Contraception (2001) 0.97
The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer. Ann Oncol (2008) 0.96
Spindle cell carcinomas of the head and neck rarely harbor transcriptionally-active human papillomavirus. Head Neck Pathol (2013) 0.96
Nasal gliomas. Arch Otolaryngol (1971) 0.95
Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso. J Nucl Med (1995) 0.92
Generating lung tumor internal target volumes from 4D-PET maximum intensity projections. Med Phys (2011) 0.91
Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells. Oncogene (2001) 0.91
Assessing tumor hypoxia by positron emission tomography with Cu-ATSM. Q J Nucl Med Mol Imaging (2009) 0.91
The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer. Anticancer Res (1997) 0.90
Evaluation of the gono-tect fluorescent antibody system for confirmation of Neisseria gonorrhoeae. Health Lab Sci (1975) 0.90
Alcohol consumption, strength of religious beliefs, and risky sexual behavior in college students. J Am Coll Health (1998) 0.90
Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro. Eur J Nucl Med (1998) 0.90
Radiologic diagnosis of chondroma and chondrosarcoma of the larynx. Arch Otolaryngol (1975) 0.89
PET in breast cancer. Semin Nucl Med (1998) 0.89
Lack of association of cadherin expression and histopathologic type, metastasis, or patient outcome in oropharyngeal squamous cell carcinoma: a tissue microarray study. Head Neck Pathol (2011) 0.89
The temperature gradient in the solar nebula. Science (1974) 0.89
FDG-PET evaluation of indeterminate pancreatic masses. J Comput Assist Tomogr (1996) 0.89
Cryosurgical management of glomus jugulare tumors. Laryngoscope (1967) 0.89
Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model. Int J Cancer (2001) 0.88